Recurrent Small Lymphocytic Lymphoma
Oncology·MeSH: Leukemia, Lymphocytic, Chronic, B-Cell
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·5 clinical trials
Frequently asked questions
How many clinical trials target Recurrent Small Lymphocytic Lymphoma?
There are 5 clinical trials targeting Recurrent Small Lymphocytic Lymphoma tracked by BioSniper.
What is the prevalence of Recurrent Small Lymphocytic Lymphoma?
The estimated prevalence of Recurrent Small Lymphocytic Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Recurrent Small Lymphocytic Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis